Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 947 M894 M953 M963 M1.03 B 3.85 B Research & development ————— — Operating income 1.13 B355 M968 M487 M1.18 B 2.99 B Non-Operating Income, Total 221 M241 M231 M202 M169 M 843 M Interest expense, net of interest capitalized 313 M300 M309 M311 M308 M 1.23 B Non-Operating Income, excl. Interest Expenses -92 M-59 M-78 M-109 M-139 M -385 M Unusual income/expense -14 M-8 M-11 M-41 M-14 M -74 M Pretax income 1.03 B296 M890 M378 M1.23 B 2.79 B Equity in earnings -16 M-17 M-18 M-19 M-15 M -69 M Taxes 242 M50 M202 M80 M303 M 635 M Non-controlling/minority interest ———0— — After tax other income/expense 36 M81 M60 M-104 M-13 M 24 M Net income before discontinued operations 791 M246 M688 M298 M924 M 2.16 B Discontinued operations ————— — Net income 791 M246 M688 M298 M924 M 2.16 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 791 M246 M688 M298 M924 M 2.16 B Basic earnings per share (Basic EPS) 2.260.681.910.812.55 5.95 Diluted earnings per share (Diluted EPS) 2.250.681.90.812.54 5.93 Average basic shares outstanding 350.1 M360.4 M360.7 M357.4 M363 M — Diluted shares outstanding 351.3 M361.7 M361.9 M358.7 M364.4 M — EBITDA 1.19 B421 M1.03 B547 M1.15 B 3.15 B EBIT 1.13 B355 M968 M483 M1.18 B 2.98 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 64 M66 M64 M64 M-28 M 166 M